A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2011
10/27/2011	US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011	US20110263555 TGR5 Modulators and Methods of Use Thereof
10/27/2011	US20110263548 Pyridone and pyridazone analogues as gpr119 modulators
10/27/2011	US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011	US20110263533 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
10/27/2011	US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011	US20110263518 D-Tagatose-Based Compositions and Methods for Preventing and Treating Atherosclerosis, Metabolic Syndrome, and Symptoms Thereof
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011	US20110263496 Exendins to lower cholesterol and triglycerides
10/27/2011	US20110263495 Methods and kits for treating disease by administering insulin-like growth factor binding protein-2
10/27/2011	US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011	US20110263493 Treatment for diabetes in patients inappropriate for metformin therapy
10/27/2011	US20110263491 Compositions and methods for the control, prevention and treatment of obesity and eating disorders
10/27/2011	US20110263490 Diagnostic Methods and Combination Therapies Involving MC4R
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262563 Compositions and methods for the prevention and treatment of cardiovascular diseases
10/27/2011	US20110262542 Controlled Delivery of Tetracycline Compounds and Tetracycline Derivatives
10/27/2011	US20110262538 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/27/2011	US20110262535 Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof
10/27/2011	US20110262534 polysaccharide capsule enclosing a fatty acid oil-containing emulsion
10/27/2011	US20110262497 Novel ezetimibe formulations
10/27/2011	US20110262445 Anti-il-12/il-23 antibodies
10/27/2011	US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011	US20110262422 Orally administrable dosage forms comprising angiogenin and uses thereof
10/27/2011	US20110262421 Pharmaceutical composition, food or drink, or feed for intestinal disease
10/27/2011	US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011	US20110262417 Composition useful for the prevention or reduction of the progression of prostate cancer
10/27/2011	US20110262407 Treatment with alpha7 selective ligands
10/27/2011	US20110262400 Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
10/27/2011	US20110262395 Sensory receptors for chronic fatigue and pain and uses thereof
10/27/2011	US20110262388 Novel inhibitors
10/27/2011	US20110262386 Methods of treating inflammation
10/27/2011	US20110262385 Use of interleukin-22 in the treatment of fatty liver disease
10/27/2011	US20110262379 Maleamic Acid Polymer Derivatives and Their Bioconjugates
10/27/2011	US20110262374 Novel compound ramalin and use thereof
10/27/2011	US20110262362 Methods for treating obesity
10/27/2011	CA2833912A1 Aav-based treatment of cholesterol-related disorders
10/27/2011	CA2797019A1 Modulators of 5-ht receptors and methods of use thereof
10/27/2011	CA2796964A1 Intermediates for the preparation of hmg-coa reductase inhibitors
10/27/2011	CA2796710A1 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
10/26/2011	EP2380884A1 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
10/26/2011	EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011	EP2380631A1 Heteroaryl derivatives as DGAT1 inhibitors
10/26/2011	EP2380582A1 Low-concentration nutritional composition
10/26/2011	EP2380578A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
10/26/2011	EP2380576A2 Methods and related compositions for reduction of fat
10/26/2011	EP2380570A1 Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof
10/26/2011	EP2380568A1 Method of producing and crystallizing reduced coenzyme Q10
10/26/2011	EP2380566A2 Treatment of insulin resistance or diseases associated with insulin resistance using steviol or isosteviol
10/26/2011	EP2379565A1 Piperidine and piperazine derivatives and methods of use thereof
10/26/2011	EP2379564A1 Bicyclic heterocyclic derivatives and methods of use thereof
10/26/2011	EP2379562A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
10/26/2011	EP2379542A1 Novel oxime derivatives
10/26/2011	EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
10/26/2011	EP2379517A1 Arylcyclopropylacetamide derivatives useful as glucokinase activators
10/26/2011	EP2379516A1 1,3,4-oxadiazole derivatives and their uses to treat diabetes
10/26/2011	EP2379511A1 Substituted diketopiperazine analogs for use as drug delivery agents
10/26/2011	EP2379100A1 Method for treating hyperglycemia with glp-1
10/26/2011	EP2379094A1 Polysaccharide from the goji berry fruit for kidneys and pancreas
10/26/2011	EP2379054A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
10/26/2011	EP2378900A2 Food supplements based on pantothenic acid
10/26/2011	EP2176250B1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
10/26/2011	EP2167069B1 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
10/26/2011	EP2129374B1 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
10/26/2011	EP1438378B1 Cholesterol lowering structured lipids with omega 6 pufa
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	EP1259481B1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
10/26/2011	CN1922313B Acid alpha-glucosidase and fragments thereof
10/26/2011	CN1901922B Compositions and uses thereof
10/26/2011	CN1813937B Compound formulation for treating hyperlipidemia and its preparing method
10/26/2011	CN1662243B Pharmaceutical composition
10/26/2011	CN102227420A Quinazolinone, quinolone and related analogs as sirtuin modulators
10/26/2011	CN102227417A Chromenone analogs as sirtuin modulators
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102227223A Mineral absorption improver, and method for improving absorption of minerals
10/26/2011	CN102225970A Extraction method of polysaccharide from potentilla discolor
10/26/2011	CN102225940A Isosorbide benzoate compound as well as preparation method and medicinal use thereof
10/26/2011	CN102225923A Method for preparing dihydromyricetin from Ampelopsis grossedentata
10/26/2011	CN102225907A Synthetic method of double bond containing 1-deoxynojirimycin derivative
10/26/2011	CN102225894A Preparation method of soluble calcium citrate trihydrate
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN102225165A Traditional Chinese medicine granule for treating type II diabetes
10/26/2011	CN102225161A Method for preparing functional components of antioxidation, blood sugar reduction and cholesterol reduction by using rice bran
10/26/2011	CN102225152A Preparation method of Maiwei rehmannia oral preparation
10/26/2011	CN102225149A Traditional Chinese medicine compound for treating diabetes and preparation method thereof
10/26/2011	CN102225132A Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof
10/26/2011	CN102225122A Caffeine-free tea polyphenol and preparation method thereof
10/26/2011	CN102225106A Propolis wine with berchemia lineate and preparation method thereof
10/26/2011	CN102225095A Effective fraction of plantain seeds as well as preparation method and application thereof
10/26/2011	CN102225086A Pharmaceutical composition for treating diabetes and preparation method thereof
10/26/2011	CN102225084A Processing process of Chinese medicinal decoction pieces of dogbane leaves
10/26/2011	CN102225083A Pharmaceutical composition and application thereof
10/26/2011	CN102225082A Medicament for preventing and treating diabetes and complications thereof and preparation method thereof
10/26/2011	CN102225080A Method for extracting flavonoid compounds from passion fruit leaves by ethanol-microwave soaking leaching process
10/26/2011	CN102225078A 抗肥胖剂及抗肥胖食品 Anti-obesity agents and anti-obesity food
10/26/2011	CN102225070A Calcium carbonate effervescent granule
10/26/2011	CN102225048A Curcumin compound injection and intravenous injection preparation thereof
10/26/2011	CN102225047A Enteric solid oral dosage form of bisphosphonate containing a chelating agent
10/26/2011	CN102224968A Rumex beverage and preparation method thereof

1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 1298